Clinical Trial Detail

NCT ID NCT02301988
Title A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Patients With Early Stage Triple Negative Breast Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements yes
Sponsors Genentech, Inc.
Indications

Her2-receptor negative breast cancer

Therapies

Paclitaxel

Ipatasertib

Age Groups: adult

Additional content available in CKB BOOST